Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2026-03-02 @ 8:03 PM
Study NCT ID:
NCT01823835
Status:
TERMINATED
Last Update Posted:
2021-06-18
First Post:
2013-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of GDC-0810 Single Agent or in Combination With Palbociclib and/or a Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Sponsor:
Genentech, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-12-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-13
Completion Date Type:
ACTUAL
First Submit Date:
2013-03-25
First Submit QC Date:
None
Study First Post Date:
2013-04-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-02-23
Results First Submit QC Date:
None
Results First Post Date:
2021-06-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-05-25
Last Update Post Date:
2021-06-18
Last Update Post Date Type:
ACTUAL